New computer-based platform could make drug discovery process more efficient and less expensive

Researchers at The University of Texas at Dallas and Novartis Pharmaceuticals Corp. have devised a computer-based platform for drug discovery that could make the process more effective, more efficient and less costly.

Related Keywords

Dallas ,Texas ,United States ,Andac Demir ,Ignacio Segovia Dominguez ,Baris Coskunuzer ,Bulent Kiziltan ,Emily Henderson ,Professor Of Mathematical Sciences ,Ai Innovation Lab ,Office Of Naval Research ,University Of Texas At Dallas ,National Science Foundation ,Temple University ,Novartis ,School Of Natural Sciences ,Erik Jonsson School Of Engineering ,Simons Foundation ,Novartis Pharmaceuticals Corp ,Novartis Pharmaceuticals ,Neural Information Processing Systems ,Mathematical Sciences ,Discovery Industry Focus ,Yulia Gel ,Natural Sciences ,Erik Jonsson School ,Yuzhou Chen ,Drug Discovery ,Clinical Testing ,Compound ,Laboratory ,Pharmaceuticals ,Research ,